Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Molecular Cancer Research : MCR|September 28, 2023
Whole-Exome Sequencing Identifies Mutation Profile and Mutation Signature-Based Clustering Associated with Prognosis in Appendiceal Pseudomyxoma PeritoneiYu-Lin Lin, Jun-Qi Zhu, Rui-Qing Ma, et al.
Oncology|December 13, 2018
CpG Island Methylator Phenotype May Predict Poor Overall Survival of Patients with Stage IV Colorectal CancerKuo-Hsing Chen, Liang-In Lin, Li-Hui Tseng, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|March 8, 2023
Effect of standardized fluid management on cardiac function after CRS + HIPEC in patients with PMP: a single-center case-control studyRui Yang, Yan-Dong Su, Gang Liu, et al.
Oncology|July 12, 2014
Phase II multicentered study of low-dose everolimus plus cisplatin and weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin as first-line treatment for patients with advanced gastric cancerYing-Chun Shen, Chung-Pin Li, Chia-Jui Yen, et al.
Cellular & Molecular Immunology|January 24, 2024
Disulfiram ameliorates STING/MITA-dependent inflammation and autoimmunity by targeting RNF115Zhi-Dong Zhang, Chang-Rui Shi, Fang-Xu Li, et al.
Reproductive Biomedicine Online|July 17, 2022
Factors influencing mosaicism: a retrospective analysisQiu-Xiang Huang, Zhi-Hong Wang, Wu-Jian Huang, et al.
European Journal of Cancer (Oxford, England : 1990)|November 26, 2019
A multicenter, phase I/II trial of biweekly S-1, leucovorin, oxaliplatin and gemcitabine in metastatic pancreatic adenocarcinoma-TCOG T1211 studyNai-Jung Chiang, Kelvin K Tsai, Chin-Fu Hsiao, et al.
Translational Oncology|June 5, 2013
Oxaliplatin-based Chemotherapy Might Provide Longer Progression-Free Survival in KRAS Mutant Metastatic Colorectal CancerYu-Lin Lin, Jau-Yu Liau, Shan-Chi Yu, et al.
Medical Oncology (Northwood, London, England)|April 2, 2016
BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancerKuo-Hsing Chen, Yu-Lin Lin, Jau-Yu Liau, et al.
Anticancer Research|July 1, 2015
Cetuximab Might Be Detrimental to Metastatic Colorectal Cancer Patients with KRAS Codon 12 MutationsYi-Hsin Liang, Yu-Lin Lin, Jau-Yu Liau, et al.
Pageof 7